City of Hope is at the
2025 ASTRO Annual Meeting

City of Hope's Department of Radiation Oncology has long been at the forefront of providing the best evidence-based clinical care, forging technological advances and translating discoveries from the bench into clinical practice.

In the global pursuit of scientific miracles in the fight against deadly diseases, the Beckman Research Institute of City of Hope is among those leading the charge. Its world-renowned staff have been responsible for fundamentally expanding the world’s understanding of how biology affects diseases such as cancer, HIV/AIDS and diabetes.

City of Hope has joined forces with the TGen to accelerate the speed with which scientists and medical staff convert research discoveries into cures for patients. The alliance is based on a simple premise: City of Hope provides a state-of-the-art clinical setting in which to advance genomic breakthroughs made by TGen.

We’re aggressively pursuing ways to help our patients right now — not years from now. That immediacy of focus makes City of Hope a worldwide leader in administering clinical trials. Each year, we conduct more than 730 clinical trials, enrolling more than 5,000 patients.

We are a leader in clinical and translational research, most notably in antibody-based therapy, CAR T cell therapy and bone marrow transplant approaches. When you refer your patient to City of Hope, you can do so with the utmost confidence that our staff will provide the best care possible for your patient.

City of Hope is ever-expanding — whether it’s at our main campus in Duarte, California, the Orange County campus or one of our 30+ clinical network locations. In order to provide premier care throughout Southern California, we seek physicians with a passion for high-quality patient care.